Born to be anxious: Neuroendocrine and genetic correlates of trait anxiety in HAB rats

Stress

Volumn 6, Issue 2, 2003, Pages 111-119

  Landgraf, R ^a   Wigger, A ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Anxiety; Candidate gene; HAB; HPA axis; Polymorphism; Vasopressin

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; DNA; GENE PRODUCT; NEUROPEPTIDE; OXYTOCIN; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; VASOPRESSIN;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANXIETY; CONFERENCE PAPER; DEPRESSION; DRUG EFFECT; EMOTION; FORCED SWIMMING TEST; GENE MAPPING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOME; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROENDOCRINOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL INTERACTION;

ANIMALS; ANXIETY; DISEASE MODELS, ANIMAL; NEUROSECRETORY SYSTEMS; RATS; RATS, WISTAR;

EID: 0037534926     PISSN: 10253890     EISSN: None     Source Type: Journal    
DOI: 10.1080/1025389031000104193     Document Type: Conference Paper

References (44)

1. Altemus, M., Smith, M.A., Diep, V., Aulakh, C.S. and Murphy, D.L. (1995) Increased mRNA for corticotropin releasing hormones in the amygdala of Fawn-Hooded rats: a potential animal model of anxiety, Anxiety 1, 251-257.
2. Arborelius, L., Owens, M.J., Plotsky, P.M. and Nemeroff, C.B. (1999) The role of corticotropin-releasing factor in depression and anxiety disorders, J. Endocrinol. 160, 1-12.
3. Baby, S., Nguyen, M., Tran, D. and Raffa, R.B. (1999) Substance P antagonists: the next breakthrough in treating depression?, J. Clin. Pharm. Ther. 24, 461-469.
4. Bakshi, V.P. and Kalin, N.H. (2002) Animal models and endophenotypes of anxiety and stress disorders, In: Davis, K.L., Charney, D., Coyle, J.T. and Nemeroff, C., eds, Neuropsychopharmacology: The 5th Generation of Progress (Lippincott Williams & Wilkins, New York), pp 883-900.
5. Bale, T.L., Davis, A.M., Auger, A.P., Dorsa, D.M. and McCarthy, M.M. (2001) CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior, J. Neurosci. 21, 2546-2552.
6. Chaouloff, F., Castanon, N. and Mormède, P. (1994) Paradoxical differences in animal models of anxiety among the Roman rat lines, Neurosci. Lett. 182, 217-221.
7. Courvoisier, H., Bihoreau, M.T., Gauguier, D., Plomin, C., Mormède, P. and Moisan, M.P. (1997) Integrated genetic mapping of 64 rat microsatellite markers from different sources, Mamm. Genome 8, 282-283.
8. Crabbe, J.C., Wahlsten, D. and Dudek, B.C. (1999) Genetics of mouse behavior: interactions with laboratory environment, Science 284, 1670-1672.
9. Driscoll, P., Escorihuela, R.M., Fernández-Teruel, A., Giorgi, O., Schwegler, H., Steimer, Th., Wiersma, A., Corda, M.G., Flint, J., Koolhaas, J.M., Langhans, W., Schulz, P.E., Siegel, J. and Tobena, A. (1998) Genetic selection and differential stress responses: the Roman lines/strains of rats, Ann. NY Acad. Sci. 851, 501-510.
10. Fernandez-Teruel, A., Escorihuela, R.M., Gray, J.A., Aguilar, R., Gil, L., Gimenez-Llort, L., Tobena, A., Bhomra, A., Nicod, A., Mott, R., Driscoll, P., Dawson, G.R. and Flint, J. (2002) A quantitative trait locus influencing anxiety in the laboratory rat, Genome Res. 12, 618-626.
11. Glatt, C.E. and Freimer, N.B. (2002) Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign, Trends Genet. 18, 307-312.
12. Gómez, F., Graugés, P., López-Calderón, A. and Armario, A. (1999) Abnormalities of hypothalamic-pituitary-adrenal and hypothalamicsomatrotrophic axes in Fawn-Hooded rats, Eur. J. Endocrinol. 141, 290-296.
13. Griebel, G., Simiand, J., Serradeil-LeGal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P. and Soubrie, P. (2002) Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR 149415, suggest an innovative approach for the treatment of stress-related disorders, Proc. Natl Acad. Sci. USA 99, 6370-6375.
14. Heinrichs, S.C., De Souza, E.B., Schultheis, G., Lapsansky, J. and Grigoriadis, D.E. (2002) Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin-releasing factor type 1 receptor selective antagonist, Neuropsychopharmacology 27, 194-202.
15. Henniger, M.S.H., Ohl, F., Hölter, S.M., Weißenbacher, P., Toschi, N., Lörscher, P., Wigger, A., Spanagel, R. and Landgraf, R. (2000) Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour, Behav. Brain Res. 111, 153-163.
16. Keck, M.E., Welt, T., Post, A., Müller, M.B., Toschi, N., Wigger, A., Landgraf, R., Holsboer, F. and Engelmann, M. (2001a) Neuroendcrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects, Neuropsychopharmacology 24, 337-349.
17. Keck, M.E., Welt, T., Wigger, A., Renner, U., Engelmann, M., Holsboer, F. and Landgraf, R. (2001b) The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats, Eur. J. Neurosci. 13, 373-380.
18. Keck, M.E., Wigger, A., Welt, T., Müller, M.B., Gesing, A., Reul, J.H.M.H., Holsboer, F., Landgraf, R. and Neumann, I.D. (2002) Vasopressin mediates the response of the combined dexamethason/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders, Neuropsychopharmacology 26, 94-105.
19. Keck, M.E., Welt, T., Müller, M.B., Uhr, M., Ohl, F., Wigger, A., Toschi, N., Holsboer, F. and Landgraf, R. (2003) Downregulation of hypothalamic vasopressinergic hyperdrive is involved in clinically relevant behavioral and neuroendocrine antidepressant drug effects, Neuropsychopharmacology 28, 235-243.
20. Landgraf, R., Gerstberger, R., Montkowski, A., Probst, J.C., Wotjak, C.T., Holsboer, F. and Engelmann, M. (1995) V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats, J. Neurosci. 15, 4250-4258.
21. Landgraf, R., Wigger, A., Holsboer, F. and Neumann, I.D. (1999) Hyperreactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour, J. Neuroendocrinol. 11, 405-407.
22. Landgraf, R. and Wigger, A. (2002) High versus low anxiety-related behavior rats: an animal model of extremes in trait anxiety, Behav. Genet. 32, 301-314.
23. Liebsch, G., Wotjak, C.T., Landgraf, R. and Engelmann, M. (1996) Septal vasopressin modulates anxiety-related behaviour in rats, Neurosci. Lett. 217, 101-104.
24. Liebsch, G., Linthorst, A.C.E., Neumann, I.D., Reul, J.M.H.M., Holsboer, F. and Landgraf, R. (1998) Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior, Neuropsychopharmacology 19, 381-396.
25. Neumann, I.D., Wigger, A., Liebsch, G., Holsboer, F. and Landgraf, R. (1998) Increased basal activity of the hypothalamo-pituitary-adrenal axis during pregnancy in rats bred for high anxiety-related behaviour, Psychoneuroendocrinology 23, 449-463.
26. Neumann, I.D., Wigger, A., Torner, L., Holsboer, F. and Landgraf, R. (2000) Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus, J. Neuroendocrinol. 12, 235-243.
27. Ohl, F., Toschi, N., Wigger, A., Henniger, M.S.H. and Landgraf, R. (2001) Dimensions of emotionality in a rat model of trait anxiety, Behav. Neurosci. 115, 429-436.
28. Palanza, P. (2001) Animal models of anxiety and depression: how are females different?, Neurosci. Biobehav. Rev. 25, 219-233.
29. Paterson, A., Whiting, P.J., Gray, J.A., Flint, J. and Dawson, G.R. (2001) Lack of consistent behavioural effects of Maudsley reactive and nonreactive rats in a number of animal tests of anxiety and activity, Psychopharmacology 154, 336-342.
30. Pitkow, L.J., Sharer, C.A., Ren, X., Insel, T.R., Terwilliger, E.F. and Young, L.J. (2001) Facilitation of affiliation and pair-bond formation by vasopressin receptor gene transfer into the ventral forebrain of a monogamous vole, J. Neurosci. 21, 7392-7396.
31. Ressler, K.J. and Nemeroff, C.B. (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders, Depress. Anxiety 12(Suppl. 1), 2-19.
32. Rosen, J.B. and Schulkin, J. (1998) From normal fear to pathological anxiety, Psychol. Rev. 105, 325-350.
33. Salomé, N., Viltart, O., Darnaudéry, M., Salchner, P., Singewald, N., Landgraf, R., Sequeira, H. and Wigger, A. (2002) Reliability of high and low anxiety-related behaviour: influence of laboratory environment and multifactorial analysis, Behav. Brain Res. 136, 227-237.
34. Salomé, N., Salchner, P., Viltart, O., Wigger, A., Sequeira, H., Landgraf, R. and Singewald, N. (2003) "Neurobiological correlates of high versus low anxiety-related behavior: a Fos study in HAB and LAB rats", Submitted for Publication.
35. Serikawa, T., Kuramoto, T., Hilbert, P., Mori, M., Yamada, J., Dubay, C.J., Lindpainter, K., Ganten, D., Guénet, J.L., Lathrop, G.M. and Beckmann, J.S. (1992) Rat gene mapping using PCR-analyzed microsatellites, Genetics 131, 701-721.
36. Strakhova, M.I. and Skolnick, P. (2001) Can differential display methodologies make an impact on biological psychiatry?, Int. J. Neuropsychopharmacol. 4, 75-82.
37. Tabor, H.K., Risch, N.J. and Myers, R.M. (2002) Candidate-gene approaches for studying complex genetic traits: practical considerations, Nat. Rev. Gen. 3, 1-7.
38. Tornatzky, W. and Miczek, K.A. (1994) Behavioral and autonomic responses to intermittent social stress: differential protection by clonidine and metoprolol, Psychopharmacology 116, 346-356.
39. Windle, R.J., Shanks, N., Lightman, S.L. and Ingram, C.D. (1997) Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats, Endocrinology 138, 2829-2834.
40. Wigger, A., Loerscher, P., Weissenbacher, P., Holsboer, F. and Landgraf, R. (2001) Cross-fostering and cross-breeding of HAB and LAB rats: a genetic rat model of anxiety, Behav. Genet. 31, 371-382.
41. Wigger, A., Sánchez, M.M., Mathys, K.C., Ebner, K., Liu, D., Kresse, A., Neumann, I.D. Holsboer, F., Plotsky, P.M. and Landgraf, R. (2003) Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin, Submitted for Publication.
42. Van Gaalen, M.M., Stenzel Poore, M.P., Holsboer, F. and Steckler, T. (2002) Effects of transgenic overproduction of CRH on anxiety-like behaviour, Eur. J. Neurosci. 15, 2007-2015.
43. Yilmazer-Hanke, D.M., Faber-Zuschratter, H., Linke, R. and Schwegler, H. (2002) Contribution of amygdala neurons containing peptides and calcium-binding proteins to fear-potentiated startle and explorationrelated anxiety in inbred Roman high- and low-avoidance rats, Eur J. Neurosci. 15, 1206-1218.
44. Young, L.J. (2001) Oxytocin and vasopressin as candidate genes for psychiatric disorders: lessons from animal models, Am. J. Med. Genet. (Neuropsychiatr. Genet.) 105, 53-54.